Blog
Adipotide: fat-targeting research and the kidney findings
The study targets a tissue support system rather than simply measuring appetite. Its interpretation depends on both the metabolic observations and the kidney effects.
Evidence discussed: Non-human primate study.
What the researchers studied
A study in obese Old World monkeys tested a compound targeting blood vessels supplying white fat. Researchers reported reduced weight and adipose tissue, supported by imaging, alongside improved measures of insulin resistance. [1]
How to interpret the result
The same work described changes in kidney proximal-tubule function. Reported reversibility under experimental conditions does not remove this safety concern. A primate experiment is not proof of long-term safety or clinical benefit in humans.
What readers can take from it
The study targets a tissue support system rather than simply measuring appetite. Its interpretation depends on both the metabolic observations and the kidney effects.
This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.
Source
[1] Adipotide and white-fat targeting in obese monkeys (2011). PMID: 22072637. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.